These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24296059)

  • 1. Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient.
    Wang YK; Hwang DY; Wang SS; Hwang SJ; Chen LT; Kuo MC
    Kaohsiung J Med Sci; 2013 Dec; 29(12):691-4. PubMed ID: 24296059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terlipressin-induced hyponatremic seizure.
    Hyun JJ; Seo YS; Lee KG; Keum B; Yim HJ; Jeen YT; Chun HJ; Um SH; Kim CD; Ryu HS
    Scand J Gastroenterol; 2010 Apr; 45(4):501-4. PubMed ID: 20302535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.
    Solà E; Lens S; Guevara M; Martín-Llahí M; Fagundes C; Pereira G; Pavesi M; Fernández J; González-Abraldes J; Escorsell A; Mas A; Bosch J; Arroyo V; Ginès P
    Hepatology; 2010 Nov; 52(5):1783-90. PubMed ID: 20931555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terlipressin-induced hyponatremic seizure in a child.
    Zaki SA
    Indian J Pharmacol; 2013; 45(4):403-4. PubMed ID: 24014921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe hyponatraemia to terlipressin treatment].
    Poulsen A; Krag A
    Ugeskr Laeger; 2013 Sep; 175(39):2250-1. PubMed ID: 24063710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terlipressin Induced Severe Hyponatremia.
    Šíma M; Pokorný M; Paďour F; Slanař O
    Prague Med Rep; 2016; 117(1):68-72. PubMed ID: 26995205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Developing Hyponatremia During Terlipressin Treatment: A Retrospective Analyses in Variceal Bleeding.
    Yim SY; Seo YS; Jung CH; Kim TH; Kim ES; Keum B; Kim JH; An H; Yim HJ; Yeon JE; Jeen YT; Lee HS; Chun HJ; Byun KS; Um SH; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Aug; 49(7):607-12. PubMed ID: 25216384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyponatraemia induced by terlipressin: a case report and literature review.
    Huang Y; Wang M; Wang J
    J Clin Pharm Ther; 2015 Dec; 40(6):626-8. PubMed ID: 26573870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial ablation complicated by fatal hyponatremic encephalopathy.
    Arieff AI; Ayus JC
    JAMA; 1993 Sep; 270(10):1230-2. PubMed ID: 8355387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
    Saner FH; Canbay A; Gerken G; Broelsch CE
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Hyponatremia Associated With Terlipressin Use in Esophageal Variceal Bleeding.
    AlKindi F; AlHaj O; Alhanaee A; Almazrouei R; Boobes Y
    Cureus; 2024 Jul; 16(7):e64576. PubMed ID: 39144872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic skin necrosis following terlipressin therapy: report of two cases and review of the literature.
    Taşliyurt T; Kutlutürk F; Erdemır F; Yelken BM; Yilmaz A; Kisacik B; Aytan P; Köseoğlu RD
    Turk J Gastroenterol; 2012; 23(6):788-91. PubMed ID: 23864457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure.
    Prakoso E; Jones C; Koorey DJ; Strasser SI; Bowen D; McCaughan GW; Shackel NA
    Intern Med J; 2013 Mar; 43(3):240-6. PubMed ID: 23176166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention.
    Krag A; Pedersen EB; Møller S; Bendtsen F
    Scand J Clin Lab Invest; 2011 Apr; 71(2):112-6. PubMed ID: 21080762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
    Walker S; Kreichgauer HP; Bode JC
    Z Gastroenterol; 1996 Oct; 34(10):692-8. PubMed ID: 8921578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyponatremia in patients treated with terlipressin: mechanisms and implications for clinical practice.
    Krag A; Møller S; Bendtsen F
    Hepatology; 2011 Jan; 53(1):368-9; author reply 369-70. PubMed ID: 21254188
    [No Abstract]   [Full Text] [Related]  

  • 19. Terlipressin-induced ischemic skin necrosis: a rare association.
    Ozel Coskun BD; Karaman A; Gorkem H; Buğday I; Poyrazoğlu OK; Senel F
    Am J Case Rep; 2014 Oct; 15():476-9. PubMed ID: 25360696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.